NRIX Nurix Therapeutics Inc
440
$16.99
$0.40
(2.41%)
| Watchers | 440 |
| 52-Wk Low | $4.22 |
| 52-Wk High | $18.12 |
| Market Cap | $984.08M |
| Volume | 319,348.00 |
| 52-Wk High | $18.12 |
| 52-Wk Low | $4.22 |
Key Takeaways From Nurix Therapeutics Analyst RatingsBenzinga • 6 days ago
Latest Ratings for NRIX
DateFirmActionFromTo Feb 2022Wells FargoInitiates Coverage OnEqual-Weight Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Oct 2021SVB LeerinkMaintainsOutperform...
Share to Feed
U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday.
read more...
SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat...
Two-year extension of ongoing research collaboration intended to generate multiple additional clinical candidates Nurix will receive a $15.0 million extension fee, and will remain eligible for...
Investors considering a purchase of Nurix Therapeutics Inc (NRIX) stock, but cautious about paying the going market price of 15.09/share, might benefit from considering selling puts among the...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Researchers will apply the latest TPD drug discovery technology to target fusion proteins that cause pediatric cancer Cancer Grand Challenges is an initiative funded by Cancer Research UK SAN...
Presentation highlights Nurix's innovation and leadership in targeted protein modulation, including ligase inhibition Unique mechanism of action, an intramolecular glue, locks the E3 ligase Casitas...
This indicator may be signaling that NRIX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Nurix Therapeutics, Inc. (NASDAQ:NRIX Get Free Report) traded down 3.8% during mid-day trading on Friday . The company traded as low as $13.49 and last traded at $13.50. 522,814 shares were...